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The neuroendocrine carcinoma is defined as a high-grade malignant neuroendocrine neoplasm arising from enterochromaffin
cells, usually disposed in the mucosa of gastric and respiratory tracts. The localization in the gallbladder is rare. Knowledge of
these gallbladder tumors is limited and based on isolated case reports. We describe a case of an incidental finding of small cell
neuroendocrine carcinoma of the gallbladder, observed after cholecystectomy for cholelithiasis, in a 55-year-old female, who
already underwent quadrantectomy and sentinel lymph-node biopsy for breast cancer. The patient underwent radiotherapy for
breast cancer and six cycles of chemotherapy with cisplatin and etoposide. Eighteen months after surgery, the patient was free from
disease. Small cell neuroendocrine carcinoma of the gallbladder has poor prognosis. Because of the rarity of the reported cases,
specific prognostic factors have not been identified. The coexistence of small cell neuroendocrine carcinoma of the gallbladder
with anothermalignancy has been reported only once.The contemporary presence of the two neoplasms could reflect that bioactive
agents secreted by carcinoid can promote phenotypic changes in susceptible cells and induce neoplastic transformation.
1. Introduction
Neuroendocrine tumors (NETs) are rare neoplasms, arising
from enterochromaffin cells, usually disposed in the mucosa
of gastric and respiratory tracts. Neuroendocrine cells have
some biochemical and morphological characteristics: these
cells contain dense core secretory granules and lack axons
and synapses and are able to produce neurotransmitters,
neuromodulators, or neuropeptide hormones. Incidence of
NETs is 5.25 cases per 100,000 person-years in the United
States [1]. NETs most frequently arise in the gastrointestinal
tract and in the respiratory tract secondarily but can occur in
any location. According to the data collected by the Surveil-
lance, Epidemiology, and End Results (SEER) program of
National Cancer Institute of the USA in the period of 1973–
2005 using SEER 17 Registry, of 16005 of NETs of the entire
gastrointestinal system only in 229 cases (1.4%)was the origin
of the gallbladder [2].
The NETs comprise a heterogeneous group of neoplasms
that vary from low-grade malignancy tumors to tumors with
high malignancy. A recent classification published in 2010
by the World Health Organization divides NETs into three
categories [3]: neuroendocrine tumor (NET) which includes
classic carcinoid tumor, neuroendocrine carcinoma (NEC),
and mixed adenoneuroendocrine carcinoma (MANEC). A
NEC is defined as a high-grade malignant neuroendocrine
neoplasm composed of either small or intermediate to large
cells with marked nuclear atypia and a high proliferation
fraction.
NETs have a good prognosis, while NEC and MANEC
have a poor prognosis. Incidence of various types of NETs
in the entire gastrointestinal system is different; however, the
ratio of tumor with good prognosis to tumor with severe
prognosis in the gallbladder is very low in comparison to
other gastrointestinal locations [2]. Because of rarity of NEC
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of gallbladder, knowledge of these tumors is limited and
based on isolated case reports or very small series.
We describe a case of incidental small cell NEC of
the gallbladder (NEC-SC-GB) concomitant with moderately
differentiated invasive ductal carcinoma of the breast. To the
best of our knowledge, this is the first case that describes this
association.
2. Case Presentation
A55-year-old female, with symptoms related to cholelithiasis,
was admitted to our hospital. She reported a 20-day history
of intermittent right upper quadrant pain radiating to the
back, associated with nausea and bloating sensation. Her
family history included father with lung adenocarcinoma.
Her personal history included right ovary salpingectomy for
endometriosis cyst, viscerolysis for bowel obstruction caused
by adhesions, and repair of a median abdominal incisional
hernia using polypropylene mesh. A quadrantectomy and
sentinel lymph-node biopsy for moderately differentiated
invasive ductal carcinoma of the breast G2pT1cN0, with
estrogens receptors of 90%, progesterone receptors of 85%,
and HER2/neu = 1+ and Ki-67 < 14%, was performed one
month before. At the time of admission, she had normal
vital parameters and laboratory investigations. At the physical
examination, tenderness in epigastric region and in the right
upper quadrant was revealed with no evidence of jaundice.
The patient showed an abdominal ultrasound and contrast-
enhance abdominal computed tomography: lumen of the
gallbladder was occupied by numerous stones with a non-
thickened wall, no evidence of biliary dilatation was noted,
and there was no ascites.The chest X-ray revealed no unusual
findings. After a laparoscopic access, we carried out, for the
presence of numerous adhesions, an open cholecystectomy.
There was no evident locoregional lymphadenopathy.
The patient had an uneventful postoperative recovery and
was discharged home after two days. On gross inspection,
the gallbladder measured 10 cm in length, some stones
were found in its lumen, and a polypoid, whitish lesion,
in correspondence with the bottom, measuring 1,5 cm was
found in its body. Final histologic examination revealed
a neuroendocrine small cell carcinoma of the gallbladder.
Tumour was seen infiltrating into the muscular layer but
not through the serosa of the gallbladder. Resected margins
were free from tumor. Two lymph nodes measuring about
4mm were isolated from the surgical specimen: the analysis
of one lymph node revealed focal metastatic deposits of
neoplastic cells (Figure 1), whereas in the other one no
deposits of tumor cells were found. Immunohistochemical
studies revealed cells strongly positive for chromogranin
(Figure 2) and synaptophysin (Figure 3) and negative for
thyroid transcription factor-1.
Postoperative imaging studies did not show residual
disease either locally or remotely. Patient was subjected to
radiotherapy for breast cancer and six cycles of chemotherapy
with cisplatin and etoposide were administered. Eighteen
months after surgery, the patient was free from disease.
Figure 1: Focal metastatic colonization of the pericystic lymph
node.
Figure 2: Positivity of the tumor to the immunohistochemical
staining for chromogranin.
3. Discussion
NEC-SC-GB was described by Albores-Saavedra et al. in 1981
[4]. Subsequently, only a case report or small series of patients
have been published [5]; however, a paucity of data on this
tumor persists; Mahipal and Gupta [6] reported that 74 cases
have been described until 2011.
Hystogenesis of NEC-SC-GB is unclear. Some authors [7]
believe that it arises from rare neuroendocrine cells normally
present in the body and fundus of the gallbladder. Other
authors believe that it originates from foci of intestinal or
gastric metaplasia [8], usually associated with long-standing
chronic inflammation due to cholelithiasis [9]. The age at
presentation has a range from 38 to 81 years with a higher
incidence in the sixth and seventh decade of life; the female
to male ratio is 2.2 [2].
Often stones are associated with the NEC-SC-GB, while
rarely it presents as an isolated lesion wall [10]. Tumor size
ranges from 0.4 cm to over 10 cm. The symptomatology has
no pathognomonic characters but is similar to that of lithiasis
in the early stageNEC-SC-GB and in the later stages is similar
to that of adenocarcinoma.
The secretory activity characteristic of NETs has rarely
been observed in NEC-SC-GB and in this case, the tumor
was in an advanced stage. Cases with symptoms of ghrelin
secretion [11] of insulin [12], of pancreatic polypeptide [13],
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Figure 3: Positivity of the tumor to the immunohistochemical
staining for synaptophysin.
of paraneoplastic sensory neuropathy [14], or of hypona-
tremia [15] have been described.
These tumors are usually diagnosed incidentally at
the histological examination of gallbladder specimens after
cholecystectomy, during autopsy, or during an ultrasound
examination or computed tomography performed for other
reasons [16]. In cases of multiple cholelithiases we should pay
particular attention to imaging investigations because calculi
can disguise cancer as we observed.
Coexistence of malignant tumors of different histologic
types with carcinoids has been a source of significant debate,
throughout the past several decades [17]. A synchronous or
metachronous neoplasia with carcinoid develops in approxi-
mately 25% of cases [17, 18]. These lesions are located more
frequently in the gastrointestinal tract. An explanation for
the high frequency is not clear. It presumably reflects the fact
that some of the bioactive agents secreted by these lesions
are known mitogens for a variety of cell types. Therefore, it is
probable that, over time, the prolonged action of such growth
factors may promote phenotypic changes in susceptible cells
and induce neoplastic transformation. To the best of our
knowledge, only Petersen et al. [19] reported a case of a
73-year-old woman with NEC-SC-GB concomitant with an
endometrioid adenocarcinoma of the ovary. Therefore, the
case that we observed represents the second case of multiple
tumors reported in the literature.
Simple cholecystectomy is probably an adequate ther-
apy for early detected and preinvasive cancer, while, for
advanced neoplasms, a more aggressive radical surgical
treatment, including radical cholecystectomy and regional
lymphadenectomy combined with a hepatic resection in
order to obtain adequate free margins, is needed [9].
Role of radiotherapy and chemotherapy remains unde-
fined because of the paucity of data of this rare disease.There
is no standard indication for adjuvant therapy, so decisions
on adjuvant therapy are based on clinical situations, such as
dissemination state, or on characteristics of the patients such
as old age, the presence of medical comorbidities, or patient’s
refusal.
Prognosis of this pathology is worse due to the advanced
nature of the disease at diagnosis [6], tumor size being
often greater than 4 cm, and also the majority of patients
presenting with liver metastases or lymph nodes or with
hepatic infiltration.
A clear assessment of prognosis ofNEC-SC-GB is difficult
due to limited knowledge, because cases described have a
limited follow-up. Kim et al. [5] and Eltawil et al. [9] reported
in a series of cases of NEC-SC-GB collected by SEER that the
5-year relative survival was 0%, despite the fact that at least
two patients had tumor size <2 cm [9]. Mahipal and Gupta
[6] in the review of literature report a median survival of 9
months with a range of 1–189 months.The few reported cases
with tumors of limited size [10, 20] have a limited follow-up
and were detected as incidental findings.
4. Conclusion
NEC-SC-GB is a rare malignancy with poor prognosis.
Because of rarity of reported cases specific prognostic factors
have not been identified, but high tumor size, depth of
invasion, and metastases are probably associated with the
prognosis. Our case has not progressed 18 months after
surgery, suggesting that aggressive multimodal treatment
may be helpful.
We emphasize the need for surgical treatment of any wall
thickening or polypoid lesion of the gallbladder in elderly
women, relying on the pathologist and immunohistochem-
istry analyses for the final diagnosis. However, presence of
gallstones can mask the tumor. Finally, although it has been
reported only two cases of multiple tumours, this possibility
should not be overlooked.
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